But this isn't like other deals or even most deals. It won International Biotech Licensing Deal of the Year, and that is because of the very generous payment schedule, the fact that Cephalon now Teva have committed to backing the technology and the FDA process and that both parties are going to benefit massively from the outcomes. IMO.
Look at his another way. Teva has already paid a significant amount to MSB. Why would they stand back and starve MSB of funds at a critical time and force them back into the market? Teva has done it's due diligence on MSB, and that means an assessment of the prospects of scientific and commercial success and made a decision to back MSB following from Cephalon. Teva has decided MSB is a significant part of it's portfolio. Why would anyone pretend otherwise?
The ONLY way Teva would "drop MSB" (as some posters in here have fancifully suggested) is if there were a significant scientific failure AND it was one which is irrecoverable. That is not one, but both elements.
Frankly what is the likelihood of that? Nobody from the negative squad will talk about it because it's not such a serious risk is it?
That's the only risk we're talking about here, and the science has been solid. And it's been assessed and reassessed and tested. We're going through an expensive clinical trials process sure we are, but how serious is the risk of total and irreversible scientific failure?
Let's be real and not speak in abstractions.
Madamswer has consistently refused to look at the science, and the commercialisation features of MSB. For this reason, his/her arguments are fundamentally flawed. (Most of the others can only talk about the shareprice, and that's not even technical analysis. Serious absence of chart analysis going on there...but it's my analysis that's deficient? Please let's be real.).
What you say does not withstand critical analysis when you separate the theory from the commercial and scientific realities. IMO.
I deal in logic and fact, not fearful speculations. I like to quantify the risks involved. Very happy with MSB's future.
MSB Price at posting:
$3.98 Sentiment: Buy Disclosure: Held
(20min delay)